Ciplacef S 1.5 g Injection

Prescription Required

Compositions : Ceftriaxone 1000mg + Sulbactam 500mg

₹152.11 (Incl. GST)

MRP :

In stock

Delivery within 2 to 7 Working Days

Manufacture/Marketer: Cipla Ltd.

Ciplacef S 1.5 g Injection is a potent pharmaceutical formulation designed to combat bacterial infections effectively. This injection combines two key active ingredients: Ceftriaxone and Sulbactam, which work synergistically to enhance therapeutic efficacy. Ceftriaxone is a broad-spectrum cephalosporin antibiotic that inhibits bacterial cell wall synthesis, thereby preventing the growth and multiplication of bacteria. Sulbactam, on the other hand, is a beta-lactamase inhibitor that protects Ceftriaxone from degradation by certain bacteria, thus extending its antibacterial activity. The primary purpose of Ciplacef S 1.5 g Injection is to treat various bacterial infections, making it an essential component in the therapeutic arsenal against resistant strains of bacteria. This combination therapy falls under the category of antibiotics and is particularly useful in treating severe infections where conventional antibiotics may fail due to resistance. Ciplacef S 1.5 g Injection is administered via injection, ensuring rapid absorption and immediate action against pathogens. The formulation is especially beneficial in hospital settings, where patients may present with complicated infections requiring aggressive treatment. By utilizing Ciplacef S 1.5 g Injection, healthcare providers can effectively manage infections that pose significant health risks, ensuring better patient outcomes. The composition of Ciplacef S 1.5 g Injection not only addresses the infection but also helps in reducing the risk of complications associated with untreated bacterial infections. Overall, Ciplacef S 1.5 g Injection represents a critical advancement in the treatment of bacterial infections, providing healthcare professionals with a reliable option for managing challenging cases.

Uses & Benefits

  • Ciplacef S 1.5 g Injection effectively treats a wide range of bacterial infections.
  • This formulation is particularly useful in managing severe infections caused by resistant bacteria.
  • Ciplacef S 1.5 g Injection helps prevent the progression of infections that could lead to serious complications.
  • It is indicated for use in both hospital and outpatient settings for various types of bacterial infections.
  • The combination of Ceftriaxone and Sulbactam enhances the overall effectiveness against tough-to-treat pathogens.
  • Ciplacef S 1.5 g Injection supports faster recovery times for patients suffering from acute bacterial infections.
  • This injection can be used in surgical prophylaxis to prevent postoperative infections.
  • Ciplacef S 1.5 g Injection is beneficial for patients with compromised immune systems who are at higher risk for infections.
How Ciplacef S 1.5 g Injection works

Ciplacef S 1.5 g Injection works through a dual mechanism of action provided by its active components, Ceftriaxone and Sulbactam. Ceftriaxone disrupts the synthesis of the bacterial cell wall, leading to cell lysis and death, while Sulbactam inhibits beta-lactamase enzymes that would otherwise deactivate Ceftriaxone's antibacterial properties.
  • Ceftriaxone binds to penicillin-binding proteins (PBPs) in bacteria, inhibiting cell wall synthesis.
  • This action leads to the weakening of the bacterial cell wall and eventual cell death.
  • Sulbactam protects Ceftriaxone from degradation by beta-lactamase-producing bacteria.
  • The combination enhances the spectrum of activity against both Gram-positive and Gram-negative bacteria.
  • Ciplacef S 1.5 g Injection is effective against strains that exhibit resistance to other antibiotics.
  • This synergy allows for a more comprehensive approach to treating complex infections.
How to use Ciplacef S 1.5 g Injection

  • Ciplacef S 1.5 g Injection should be administered by a qualified healthcare professional via intramuscular or intravenous injection.
  • The recommended dosage for adults typically ranges from 1 to 2 grams every 12 to 24 hours, depending on the severity of the infection.
  • For pediatric patients, dosing is usually based on body weight and should be determined by a healthcare provider.
  • The frequency of administration may vary based on clinical response and specific infection type.
  • Duration of treatment with Ciplacef S 1.5 g Injection generally lasts from 5 to 14 days, as directed by a physician.
  • Patients should be monitored for therapeutic effectiveness and any potential side effects during treatment.
  • Special instructions include ensuring proper hydration and monitoring for allergic reactions post-injection.
Lifestyle Advice

  • Maintain good hydration levels while receiving Ciplacef S 1.5 g Injection to support kidney function and overall health.
  • Avoid alcohol consumption during treatment to minimize potential side effects and interactions.
  • Incorporate a balanced diet rich in vitamins and minerals to support immune function during recovery from infection.
  • Engage in light physical activity as tolerated to promote circulation and overall well-being while on medication.
  • Monitor any changes in health status closely and report them to your healthcare provider promptly.

Side Effects

  • Common side effects of Ciplacef S 1.5 g Injection may include rash, diarrhea, and injection site reactions such as pain or swelling.
  • Increased liver enzymes may occur; regular monitoring is advised during treatment.
  • Some patients may experience changes in blood cell counts, such as decreased white blood cells or low platelets.
  • Serious side effects can include allergic reactions like swelling of the face or difficulty breathing; immediate medical attention is required in such cases.
  • Consult a healthcare provider if side effects persist or worsen during treatment with Ciplacef S 1.5 g Injection.

Precautions and Warnings

  • Ciplacef S 1.5 g Injection should not be used in patients with known hypersensitivity to Ceftriaxone or Sulbactam.
  • Patients with a history of severe allergic reactions to penicillins or other beta-lactam antibiotics should exercise caution.
  • Pregnant or breastfeeding women should consult their healthcare provider before using this injection.
  • Alcohol consumption should be avoided during treatment as it may exacerbate side effects.
  • Patients with liver or kidney impairment should be closely monitored while receiving Ciplacef S 1.5 g Injection.
  • Driving or operating heavy machinery should be avoided if experiencing dizziness or other side effects from the medication.
  • Consult a doctor if there are any concerns regarding drug interactions or pre-existing medical conditions before starting treatment.

1. What is Ciplacef S 1.5 g Injection used for?
Ciplacef S 1.5 g Injection is primarily used for treating various bacterial infections, especially those caused by resistant strains.
2. How should Ciplacef S 1.5 g Injection be administered?
Ciplacef S 1.5 g Injection should be administered by a healthcare professional through intramuscular or intravenous routes.
3. What are the common side effects of Ciplacef S 1.5 g Injection?
Common side effects include rash, diarrhea, and pain at the injection site; most are mild and resolve without intervention.
4. Can I drink alcohol while using Ciplacef S 1.5 g Injection?
It is advisable to avoid alcohol during treatment with Ciplacef S 1.5 g Injection due to potential interactions.
5. Is Ciplacef S 1.5 g Injection safe during pregnancy?
Pregnant women should consult their healthcare provider before using Ciplacef S 1.5 g Injection to assess risks versus benefits.
6. What should I do if I miss a dose of Ciplacef S 1.5 g Injection?
If a dose is missed, contact your healthcare provider for guidance on how to proceed; do not double up on doses.
7. How does Ciplacef S 1.5 g Injection work?
Ciplacef S 1.5 g Injection works by combining Ceftriaxone's antibiotic properties with Sulbactam's ability to inhibit beta-lactamase enzymes, enhancing its effectiveness against bacteria.

Directions for Use

Use only as prescribed by your physician.

Storage and Disposal

Please refer to the product label for storage information.

SKU 929074
Country of Manufacture India
Manufacturer Address Cipla Ltd.
Return/Buy Back policy Non-returnable
Prescription Required Yes
Storage Please refer to the product label for storage information.
Seller Kogland Commerce Pvt Ltd (TN)

Door Step Delivery

Quick and Secure

No Hidden Charges

Pay only what's shown

18K Pincodes Served

With Trust & Reliability

Customer Reviews

No reviews yet

Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.

star Login to review

Write Your Own Review

Only registered users can write reviews. Please Sign in or create an account

Please wait…

Share Your Requirements With Us

Please fill out the form below. We'll get back to you. Thank you for your patience.